We are live on ! Find out more
CSBR icon

Champions Oncology
CSBR

35 hedge funds and large institutions have $64.1M invested in Champions Oncology in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 17 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

2.92% less ownership

Funds ownership: 49.71% → 46.78% (-2.9%)

6% less capital invested

Capital invested by funds: $68.5M → $64.1M (-$4.34M)

8% less funds holding

Funds holding: 38 → 35 (-3)

53% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 17

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

Holders
35
Holders Change
-3
Holders Change %
-7.89%
% of All Funds
0.61%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
2
Increased
8
Reduced
17
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MAG
Millrace Asset Group
Pennsylvania
+$444K
2
BlackRock
BlackRock
New York
+$156K
3
ACM
ACT Capital Management
Pennsylvania
+$86.5K
4
HighTower Advisors
HighTower Advisors
Illinois
+$71.6K
5
Federated Hermes
Federated Hermes
Pennsylvania
+$60K

Top Sellers

Rank Fund Capital Flow
1
RC
Roubaix Capital
Colorado
-$3.61M
2
Millennium Management
Millennium Management
New York
-$284K
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$214K
4
OMC
Overbrook Management Corp
New York
-$137K
5
Morgan Stanley
Morgan Stanley
New York
-$131K
Name Holding Trade Value Shares
Change 		Change in
Stake
BMC
1
Battery Management Corp
Massachusetts
$24.7M – – –
NMC
2
NEA Management Company
Maryland
$17.5M – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$3.35M – – –
MAG
4
Millrace Asset Group
Pennsylvania
$3.31M +$444K +43,636 +16%
TAM
5
Tocqueville Asset Management
New York
$2.58M – – –
Renaissance Technologies
6
Renaissance Technologies
New York
$2.26M -$70.2K -6,900 -3%
BlackRock
7
BlackRock
New York
$1.25M +$156K +15,376 +14%
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
$1.22M -$109K -10,753 -8%
Bank of Montreal
9
Bank of Montreal
Ontario, Canada
$1.02M -$51.2K -5,031 -5%
EIM
10
Essex Investment Management
Massachusetts
$914K -$16.5K -1,617 -2%
OMC
11
Overbrook Management Corp
New York
$832K -$137K -13,433 -14%
Millennium Management
12
Millennium Management
New York
$617K -$284K -27,899 -32%
ACM
13
ACT Capital Management
Pennsylvania
$597K +$86.5K +8,500 +17%
CAM
14
ClariVest Asset Management
California
$575K -$3.05K -300 -0.5%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$486K +$47.7K +4,685 +11%
AC
16
Aristides Capital
Kentucky
$375K – – –
Acadian Asset Management
17
Acadian Asset Management
Massachusetts
$320K -$10 -1 -0%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$314K -$214K -21,050 -41%
E
19
Ergoteles
New York
$312K -$3.41K -335 -1%
SFI
20
Susquehanna Fundamental Investments
Pennsylvania
$290K – – –
Northern Trust
21
Northern Trust
Illinois
$285K +$1.52K +149 +0.5%
HighTower Advisors
22
HighTower Advisors
Illinois
$270K +$71.6K +7,040 +36%
State Street
23
State Street
Massachusetts
$251K +$4.07K +400 +2%
HF
24
HRT Financial
New York
$128K -$24.7K -2,426 -16%
ISL
25
Ingalls & Snyder LLC
New York
$113K – – –
1
2

CSBR Hedge Fund Activity: Q3 2021 in Review

35 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q3 2021, worth a combined $64.1M — down 6.3% from $68.5M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of CSBR and 2 opened new positions — a net loss of 3 holders — while 17 trimmed existing stakes and 8 added.

The largest buyer was Millrace Asset Group, adding an estimated $444K. The largest seller was Roubaix Capital, exiting entirely with an estimated $3.61M sold.

  • 35 institutional investors held Champions Oncology (CSBR) as of Q3 2021, down from 38 in Q2 2021.
  • Funds reported $64.1M of Champions Oncology stock for Q3 2021, down 6.3% quarter-over-quarter.
  • 2 funds opened new Champions Oncology positions in Q3 2021 and 5 closed out, a net change of -3 holders.
  • The largest Champions Oncology buyer in Q3 2021 was Millrace Asset Group, an estimated $444K added.
  • The largest Champions Oncology seller in Q3 2021 was Roubaix Capital, an estimated $3.61M sold.

Based on aggregated 13F filings for Q3 2021.